Multi-country

Alzheimer’s Pill Has Finished the Trial. Evidence Has Not.

Prevention Is Now Alzheimer’s Hardest Trial

The Novo Nordisk Foundation is going global on cardiometabolic disease.

Liver Cancer Is Moving Beyond TACE Alone

ctDNA Is Becoming the New Argument Over Chemotherapy

Microglia Are Not a Shortcut to Alzheimer’s Certainty

Military recruits appear to face far more sudden cardiac death than athletes. Screening still depends on the country

Lung Cancer May Be Entering the Chemo-Replacement Fight

A Blood Test Can See Risk. Policy Cannot Yet Hold It.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
